Submit offer Reimbursement research and strategy development for future market access planning

Template for the Task Description
  
A good Task Description must include the following:  
 
1. GENERAL INFORMATION: 
Titel of tender: Reimbursement research and strategy development for future market access planning
Your company’s name:  MultiBiopsy
Address:  Universitetsbyen 76, 8000 Aarhus C, Denmark

CVR nr.:  44304554
Date:  28.04.2026
Deadline for tender:  26.05.2026
For further questions, contact info:  William Ludvigsen, CEO 
Upload of tender info: Use link in task description
Phone and e-mail:  William.Ludvigsen@multibiopsy.com 
tlf: +45 40106428
 
2. PRESENTATION OF COMPANY: 

MultiBiopsy is a Danish early-stage MedTech company developing an innovative biopsy device for soft-tissue cancer diagnostics. The company is developing a biopsy pistol capable of retrieving multiple tissue samples from a single insertion, with the aim of improving diagnostic accuracy, lowering complication risk, reducing re-biopsy rates, and fitting naturally into current interventional radiology workflows.

The company combines clinical, engineering, and regulatory competences and has already developed a proof-of-concept needle system together with external manufacturing and development partners. MultiBiopsy is currently focused on maturing the technology, strengthening its documentation package, and preparing a robust market access and regulatory pathway for future commercialization.

 
3. DESCRIPTION OF THE TASK UNDER MARKET EVALUATION: 

MultiBiopsy seeks an external consultant with strong MedTech reimbursement and market access experience to build the company's internal competence in reimbursement research, evidence interpretation, and strategy development.

The task is focused not only on producing strategic reimbursement insights, but also on educating the MultiBiopsy team in how reimbursement processes work in practice, so the company can carry out a substantial share of future reimbursement work independently. The company therefore seeks support in understanding how to conduct structured reimbursement research, how to interpret coding, payment, and coverage dynamics, and how to translate reimbursement findings into a practical strategic direction.

The consultancy should therefore combine analytical support with competence transfer and practical learning. The task should include:

·       Mapping the relevant reimbursement research framework for the company's device category and target use case, with primary focus on the United States and room for strategic comments on selected other markets if relevant. 

·       Explaining how reimbursement processes work in practice, including how coding, payment, coverage, and hospital economics interact and influence adoption. 

·       Teaching MultiBiopsy how to assess coding, payment, and coverage logic relevant to biopsy procedures and associated hospital incentives. 

·       Reviewing how existing procedure codes, payment flows, site-of-care dynamics, and hospital incentives may affect adoption of the MultiBiopsy device. 

·       Supporting the development of a reimbursement research approach, methods, and decision framework that MultiBiopsy can continue to use internally after the consultancy. 

·       Providing guidance on which data sources, payer insights, coding assumptions, benchmarks, and expert interviews should be prioritized in future work. 

·       Translating the findings into a practical reimbursement strategy, including key uncertainties, evidence needs, and market access implications. 

·       Delivering a written strategic output and one or more competence-building workshops or working sessions designed to ensure that the team can independently perform significant parts of the reimbursement and market access work going forward.

 4. TASK OBJECTIVES AND SUCCESS CRITERIA: 

The goal of the task is to enable MultiBiopsy to make more informed reimbursement-related decisions and to reduce uncertainty around future payment logic and hospital adoption incentives.

A satisfactory result should give MultiBiopsy both a better decision basis and a reusable way of working with reimbursement questions in future fundraising, regulatory planning, and commercialization work.

·       A clear explanation is delivered of how reimbursement research for this type of MedTech solution should be conducted.

·       The company receives a structured overview of relevant reimbursement components such as coding, payment, coverage, and site-of-care implications.

·       The consultant delivers a guiding and assistance in defining the right reimbursement strategy.

·       Key assumptions, risks, and missing information are identified explicitly rather than left implicit.

·       The team completes at least one workshop or transfer session and is left with tools, templates, or frameworks it can reuse.

·       The final output includes a prioritized next-step plan for reimbursement discovery, expert engagement, and strategic follow-up.

5. BUDGET OG SPECIFICATION OF AN OFFER: 

MultiBiopsy requests a written offer for the advisory and competence-building task described above. The service must be limited to analysis, guidance, documentation support, strategic planning input, and structured competence development. Execution or implementation services beyond advisory support are outside scope.

The expected total budget for this task is approximately 50,000 DKK excl VAT, and bidders are requested to structure their offer within this budget level.

Additional expectations for this tender:

•             Demonstrate direct experience with reimbursement strategy for medical devices, preferably in procedure-based hospital settings.

•             Describe relevant experience with U.S. coding, payment, coverage, and hospital economics, preferably from a relevant company.

•             Explain how the bidder will separate validated insights from assumptions and emerging hypotheses.

•             Specify what deliverable format will be used for the final reimbursement strategy and capability-building output.

 
6. BACKGROUND FOR THE TENDER: 
Beyond Beta is subject to a number of requirements for good, healthy financial management, including documentation that the agreed price for external purchases is an expression of the market price. This tender is part of these requirements. 
We emphasize that the bidder must only make an offer on the requested task.  
Services of executing or implementing nature cannot be approved  
The winning bid is chosen based on an assessment of the best correlation between price and quality